Loading...
Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Diabetes Association
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3920795/ https://ncbi.nlm.nih.gov/pubmed/23882041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dcS13-2031 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|